#eisai — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #eisai, aggregated by home.social.
-
https://www.europesays.com/at/43717/ Eisai präsentiert neue Langzeitdaten zu Alzheimer-Mittel Leqembi #AlzheimerForschung #AlzheimerMittel #ApoE4 #AT #Austria #Eisai #Gesundheit #Health #Langzeitdaten #Leqembi #Österreich #patienten #Risikogen #Studienergebnisse #Therapien
-
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to approaching the brain-wasting disease as a system of complex pathways. https://www.japantimes.co.jp/news/2025/12/12/world/science-health/alzheimers-trials-shift-approach/?utm_medium=Social&utm_source=mastodon #worldnews #sciencehealth #aging #dementia #alzheimer039s #pharmaceuticals #medicine #eisai #novonordisk
-
A health ministry panel approved a plan to cut the price of Lecanemab, an Alzheimer's drug that Japanese drugmaker Eisai and U.S. industry peer Biogen codeveloped, by 15% in Japan starting Nov. 1. https://www.japantimes.co.jp/news/2025/08/07/japan/science-health/japan-alzheimer-drug-price-cut/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimer039s #medicine #pharmaceuticals #eisai #health
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Ebisu-jinja was established by Myōan Eisai (明菴栄西) in 1202 to act as guardian for Kennin-ji (then being built), and to thank the god Ebisu for saving him from a storm when returning from the mainland.
Eisai is credited with bringing the Rinzai school of Zen and the tradition of tea-drinking to Japan.
-
Ebisu-jinja was established by Myōan Eisai (明菴栄西) in 1202 to act as guardian for Kennin-ji (then being built), and to thank the god Ebisu for saving him from a storm when returning from the mainland.
Eisai is credited with bringing the Rinzai school of Zen and the tradition of tea-drinking to Japan.
-
Ebisu-jinja was established by Myōan Eisai (明菴栄西) in 1202 to act as guardian for Kennin-ji (then being built), and to thank the god Ebisu for saving him from a storm when returning from the mainland.
Eisai is credited with bringing the Rinzai school of Zen and the tradition of tea-drinking to Japan.
-
Ebisu-jinja was established by Myōan Eisai (明菴栄西) in 1202 to act as guardian for Kennin-ji (then being built), and to thank the god Ebisu for saving him from a storm when returning from the mainland.
Eisai is credited with bringing the Rinzai school of Zen and the tradition of tea-drinking to Japan.
-
Ebisu-jinja was established by Myōan Eisai (明菴栄西) in 1202 to act as guardian for Kennin-ji (then being built), and to thank the god Ebisu for saving him from a storm when returning from the mainland.
Eisai is credited with bringing the Rinzai school of Zen and the tradition of tea-drinking to Japan.
-
Japan's health ministry on Tuesday approved the production and sale of a new medicine for ALS, raising hopes among patients. https://www.japantimes.co.jp/news/2024/09/24/japan/science-health/japan-new-als-drug-approve/ #japan #sciencehealth #als #eisai #mecobalamin
-
Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years. https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/ #worldnews #sciencehealth #dementia #aging #alzheimer039s #eisai #biogen #elililly #drugs #medicine #brain
-
Britain's medicine regulator said Thursday that it approved a novel Alzheimer's drug developed jointly by Japanese drugmaker Eisai and U.S. partner Biogen. https://www.japantimes.co.jp/news/2024/08/23/japan/britain-eisai-drug/ #japan #eisai #alzheimers #drugs #uk
-
European Medicines Agency approves 14 new medicines but rejects new Alzheimer’s drug https://www.euractiv.com/section/health-consumers/news/european-medicines-agency-approves-14-new-medicines-but-rejects-new-alzheimers-drug/?utm_source=dlvr.it&utm_medium=mastodon #AlzheimersDisease #Biogen #Eisai #Leqembi #novonordisk
-
Europe's medicines watchdog has rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits. https://www.japantimes.co.jp/news/2024/07/27/japan/science-health/europe-watchdog-alzheimers-drug/ #japan #sciencehealth #eisai #alzheimer039s #aging #health #dementia #medicine
-
Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset—BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival —Supreme Court’s Chevron Doctrine ruling could limit FDA’s regulatory authority—http://bit.ly/w28kSd #gileadsciences #cancer #antibodydrugconjufate #eisai #bristolmyerssquibb #supremecourt #fda #chevrondoctrine #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Moderna’s COVID-Flu combo shot beats separate vaccines in phase III study—FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date — Boehringer, Lilly face off in MASH at EASL—http://bit.ly/w28kSd #moderna #vaccines #flu #covid19 #alzheimers #fda #eisai #biogen #elililly #mash #easl #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
The writings of the monks Eisai and Dogen sought to determine the proper way to live on this Earth, in harmony with the Way. https://www.japantimes.co.jp/news/2024/05/17/japan/history/joy-zen-japanese-history/ #japan #history #zenbuddhism #dogen #eisai #kamakuraperiod
-
The writings of the monks Eisai and Dogen sought to determine the proper way to live on this Earth, in harmony with the Way. https://www.japantimes.co.jp/news/2024/05/17/japan/history/joy-zen-japanese-history/ #japan #history #zenbuddhism #dogen #eisai #kamakuraperiod
-
The writings of the monks Eisai and Dogen sought to determine the proper way to live on this Earth, in harmony with the Way. https://www.japantimes.co.jp/news/2024/05/17/japan/history/joy-zen-japanese-history/ #japan #history #zenbuddhism #dogen #eisai #kamakuraperiod
-
The writings of the monks Eisai and Dogen sought to determine the proper way to live on this Earth, in harmony with the Way. https://www.japantimes.co.jp/news/2024/05/17/japan/history/joy-zen-japanese-history/ #japan #history #zenbuddhism #dogen #eisai #kamakuraperiod
-
Novo Nordisk owner buys majority stake in Austrian life science tools company—As sales of weight loss drugs skyrocket, the insulin market falters —Eisai starts rolling submission for injectable version of Alzheimer's drug with FDA --http://bit.ly/w28kSd #novonordisk #mergersandacquisitions #insulin #diabetes #alzheimers #eisai #biogen #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use. https://www.japantimes.co.jp/news/2024/04/24/world/science-health/alzheimer-drug-us-adoption-slow/ #worldnews #sciencehealth #alzheimers #brain #eisai #biogen #leqembi #us
-
Biogen and Eisai fall behind on Leqembi’s subcutaneous BLA for Alzheimer’s—Teva, Viatris win new chance to challenge J&J schizophrenia drug patent—3M spins out Solventum--http://bit.ly/w28kSd #biogen #eisai #alzehimers #teva #jnj #patents #schizophrenia #3m #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Teams of researchers from Niigata University and the University of Tokyo have begun an international clinical trial to check the effectiveness and safety of a treatment for familial Alzheimer's disease. https://www.japantimes.co.jp/news/2024/03/15/japan/science-health/familial-alzheimers-treatment-trial/ #japan #sciencehealth #alzheimer039s #eisai #pharmaceuticals
-
Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects growth to accelerate significantly in 2025 as diagnosis methods change, according to a company spokesperson. https://www.japantimes.co.jp/business/2024/02/05/companies/eisai-alzheimers-drug-china/?utm_content=buffer2498b&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #business #companies #eisai #pharmaceuticals #alzheimer039s #china
-
New Alzheimer's drug lecanemab will cost around ¥2.98 million per year in Japan, but will be largely covered by public health insurance that will limit the burden for patients to between 10% and 30% of that cost, subject to a cap, a health ministry body has said. https://www.japantimes.co.jp/news/2023/12/13/japan/eisai-biogen-alzheimers-drug-price/?utm_content=buffer4dd52&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #alzheimer039s #drugs #eisai #biogen #pharmaceuticals
-
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news http://bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news http://bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
A health ministry panel reviewing the new Alzheimer’s drug lecanemab greenlighted its approval in Japan on Monday. https://www.japantimes.co.jp/news/2023/08/21/japan/science-health/lecanemab-alzheimers-drug-approval/?utm_content=buffer356e4&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #lecanemab #eisai #alzheimer039s #pharmaceuticals #health
-
Pfizer, Flagship join forces to hunt for 10 new drugs—Four crucial questions about the Humira biosimilar price war -- Medicare's proposed coverage for Alzheimer's scan could be boon for Eisai and Biogen -- See more on our front page news http://bit.ly/w28kSd #pfizer #flagshippioneering #humira #abbvie #drugdevelopment #alzheimers #biosimilar #medicare #cms #biogen #eisai #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Pfizer, Flagship join forces to hunt for 10 new drugs—Four crucial questions about the Humira biosimilar price war -- Medicare's proposed coverage for Alzheimer's scan could be boon for Eisai and Biogen -- See more on our front page news http://bit.ly/w28kSd #pfizer #flagshippioneering #humira #abbvie #drugdevelopment #alzheimers #biosimilar #medicare #cms #biogen #eisai #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Drug giant Eisai's global Alzheimer drug program officer Ivan Cheung will be replaced by the son of the firm’s CEO, after a tenure that saw Cheung lead the push for U.S. approval of breakthrough medicine Leqembi. https://www.japantimes.co.jp/news/2023/07/11/business/corporate-business/eisai-alzheimers-leqembi-ivan-cheung-ceo-son-keisuke-naito/?utm_content=bufferfeb39&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #news #corporate #pharmaceuticals #alzheimers #eisai #keisukenaito
-
Eisai’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators, a move that will help widen insurance access to the first drug cleared based on its ability to slow progression of the mind-robbing disease. https://www.japantimes.co.jp/news/2023/07/07/world/science-health-world/eisai-alzherimers-drug-u-s-approval/?utm_content=buffer46a0b&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #news #worldnews #us #health #brain #alzheimers #eisai #medicine
-
Expectations for the Alzheimer's treatment lecanemab are rising in Japan and it could be approved as early as fall, but even then there would be several barriers to its widespread adoption. https://www.japantimes.co.jp/news/2023/07/04/national/science-health/lecanemab-japan-approval-expectations/?utm_content=bufferb2b8f&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #news #japan #aging #elderly #pharmaceuticals #dementia #alzheimers #eisai #medicine
-
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price. https://www.japantimes.co.jp/news/2023/06/19/world/science-health-world/europe-alzheimers-experts-doubt-eisai-biogen-drug/?utm_content=buffer28b58&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #news #worldnews #health #brain #alzheimers #biogen #eisai
-
Nach Cyber-Angriff: #Ransomware-Befall bei Pharmaunternehmen #Eisai | Security https://www.heise.de/news/Ransomware-Angriff-Pharmaunternehmen-Eisai-nimmt-Systeme-offline-9182166.html #Malware #CyberCrime
-
FDA approves new Alzheimer’s treatment despite risks, unclear benefits - Enlarge / MRI of a human brain. (credit: Getty | BSIP)
The Foo... - https://arstechnica.com/?p=1908494 #cognitivedecline #alzheimers #treatment #antibody #approval #science #biogen #eisai #fda
